Related Experiment Video

Updated: May 16, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Streptococcus pneumoniae: elusive mechanisms of the body's defense systems

T Bondi1, C Canessa, F Lippi

  • 1Department of Pediatrics, University of Florence, Florence, Italy.

Journal of Preventive Medicine and Hygiene
|December 18, 2012
PubMed

Insights

Streptococcus pneumoniae serotype replacement after vaccination is driven by recombination, not just vaccination. Enhanced surveillance using molecular diagnostics is crucial for tracking antibiotic resistance and vaccine response.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Streptococcus pneumoniae is a major human pathogen causing pneumonia, meningitis, and otitis.
  • The introduction of the PCV7 vaccine led to a serotypic switch, with less common, potentially more invasive or resistant serotypes replacing those in the vaccine.

Purpose of the Study:

  • To investigate the mechanisms behind the observed serotypic switch in Streptococcus pneumoniae.
  • To understand the role of genetic recombination in the pathogen's adaptation and resistance development.
  • To highlight the increasing challenge of antibiotic resistance in pneumococcal infections.

Main Methods:

  • Analysis of genetic recombination events in Streptococcus pneumoniae.
  • Monitoring of serotype prevalence shifts post-vaccination.
  • Tracking of antibiotic resistance patterns, including penicillin, macrolides, and clindamycin resistance.
  • Observing the rise of multidrug-resistant bacterial isolates.

Main Results:

  • Serotypic switch is influenced by factors beyond vaccination, including the emergence and spread of new or minority serotypes.
  • Homologous recombination within and between species facilitates the development of antibiotic and vaccine resistance.
  • Significant increases in resistance to common antibiotics like penicillin, macrolides, and clindamycin have been observed.
  • A rise in multidrug-resistant Streptococcus pneumoniae isolates is a growing concern.

Conclusions:

  • Genetic recombination plays a key role in Streptococcus pneumoniae's ability to develop resistance and adapt.
  • Epidemiological surveillance must be enhanced with modern molecular techniques to understand pneumococcal evolution, antibiotic resistance, and vaccine effectiveness.
  • Continuous monitoring is essential to combat the increasing threat of multidrug-resistant pneumococcal infections.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...